Welcome to our dedicated page for Sunlink Hlth news (Ticker: SSY), a resource for investors and traders seeking the latest updates and insights on Sunlink Hlth stock.
SunLink Health Systems, Inc. (formerly NYSE American: SSY) generated a stream of news focused on its pharmacy-centered healthcare operations in the Southeast and, ultimately, its corporate combination with Regional Health Properties, Inc. News coverage for SSY traces the company’s evolution from operating hospital and long-term care assets in Mississippi to concentrating on a pharmacy business, while pursuing an extraordinary transaction to reshape its scale and capital structure.
Company press releases detail quarterly financial results in which consolidated net revenues consisted primarily of pharmacy net revenues, with commentary on institutional pharmacy activity, retail pharmacy scripts, and durable medical equipment orders. These earnings updates also discuss the impact of asset sales, such as the divestiture of Trace Regional Hospital operations, the sale of a senior care facility in Houston, Mississippi, and the sale of the Trace Regional Hospital real estate, all framed as part of a broader repositioning strategy.
A major theme in SunLink’s later news flow is the merger with Regional Health Properties, Inc. Announcements describe the entry into a definitive merger agreement, subsequent amendments extending the termination date, and the rationale for combining SunLink’s pharmacy operations with Regional’s nursing home and healthcare real estate portfolio. Press releases outline shareholder meetings, proxy voting updates, recommendations from the SunLink board, and the eventual approval of the merger by SunLink and Regional shareholders.
Additional news items cover a special cash dividend declared prior to the merger, explanations of due bill procedures for that dividend, and a notice from NYSE American that SunLink had fallen below certain continued listing standards due to not holding an annual meeting within a specified fiscal year. The culmination of this news timeline is the announcement, referenced in SunLink’s Form 8-K, that the merger with Regional closed on August 14, 2025.
This news page serves as an archive of SunLink’s historical announcements, financial updates, and merger-related communications for investors analyzing the path that led from SSY as an independent healthcare and pharmacy company to its integration into Regional Health Properties, Inc.
SunLink Health Systems, Inc. (NYSE American: SSY) reported a loss from continuing operations of $473,000 ($0.07 per share) for Q3 of fiscal 2021, a significant decline from a $46,000 loss in Q3 2020. Total net revenues fell by 22.8% to $9,778,000, primarily due to decreased revenues in its Healthcare and Pharmacy segments linked to COVID-19. For the nine months ending March 31, 2021, net revenues were $30,350,000, down 18.2% year-over-year, leading to an operating loss of $1,117,000. The company has received $5,070,000 in Provider Relief Funds to date.
SunLink Health Systems, Inc. (NYSE American: SSY) announced its Trace Forward Capital Plan, a $2 million initiative to enhance Trace Regional Hospital's facilities and services. Key upgrades include an 8-bed expansion of the Pathways Care Program, modernized patient rooms, a comprehensive replacement of heating, air conditioning, and roofing systems. The plan also includes enhanced diagnostic and IT equipment, expanding telemedicine services and improving security. These enhancements aim to meet the rising demand for senior healthcare in northeast Mississippi and are funded primarily through the hospital's cash reserves.
SunLink Health Systems (SSY) reported earnings from continuing operations of $3,146,000 ($0.46 per share) for Q2 fiscal 2021, up from $203,000 ($0.03 per share) last year.
Net earnings surged to $3,074,000 from a net loss of $42,000. However, consolidated net revenues fell 20.7% to $10,150,000, mainly due to decreased revenues in healthcare and pharmacy segments amid the COVID-19 pandemic. Operating losses were reported at $254,000 compared to profits in the same quarter last year. The company also received $5,008,000 from the Provider Relief Funds under the CARES Act.